APA

Wong P. C., Quan M. L., Saye J. M., Bernard R., Crain E. J., McCall D. E., Watson C. A., Zaspel A. M., Smith R. D. & Wexler R. R. (19960321). Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype. : Journal of cardiovascular pharmacology.

Chicago

Wong P C, Quan M L, Saye J M, Bernard R, Crain E J, McCall D E, Watson C A, Zaspel A M, Smith R D and Wexler R R. 19960321. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype. : Journal of cardiovascular pharmacology.

Harvard

Wong P. C., Quan M. L., Saye J. M., Bernard R., Crain E. J., McCall D. E., Watson C. A., Zaspel A. M., Smith R. D. and Wexler R. R. (19960321). Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype. : Journal of cardiovascular pharmacology.

MLA

Wong P C, Quan M L, Saye J M, Bernard R, Crain E J, McCall D E, Watson C A, Zaspel A M, Smith R D and Wexler R R. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype. : Journal of cardiovascular pharmacology. 19960321.